Cochlear Ltd (ASX: COH) is one of the world’s leading medical businesses. Cochlear designs, manufactures and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant. Graeme Clark invented the first device in 1982, allowing first-user Graham Carrick to hear for the first time for 17 years. Some of the most recent modifications allow users to play sound from their phone directly into their implant.
The Cochlear Limited (ASX: COH) share price bounced dramatically higher this week following a bumper report. But is the Cochlear share price looking a little expensive? Stock Doctor’s Daniel Ortisi weighs in.
Tim Lincoln is the co-founder of Lincoln Indicators. Tim Lincoln recently sat down with Owen Rask on The Australian Investors Podcast to talk about the origins of the Stock Doctor ‘financial health’ model, which is based on PhD research.
The Resmed CDI (ASX:RMD) share price bounced 6.5% higher today following the release of its Q3 results. Resmed and CSL Limited (ASX:CSL) seem good value relative to Cochlear Limited (ASX:COH).
Resmed CDI (ASX:RMD) shares and the Monash IVF Group Ltd (ASX:MVF) share price look very tempting at these prices, writes Seneca’s Luke Laretive.
The Cochlear Limited (ASX:COH) share price is under the spotlight as the hearing device business announced its FY22 result.
The Australian share market, otherwise known as S&P/ASX 200 (INDEXASX: XJO) or All Ordinaries (INDEXASX: XAO), continued on a downward trend on Wednesday, to open the month of June by falling 0.8 per cent.
It’s been a crazy few months, hasn’t it? Rates, Elections, inflation… Here’s how I’m investing right now.
Which ASX shares should you be avoiding if you’re worried about inflation? Are ASX shares like Redbubble Ltd (ASX: RBL), Cochlear Ltd (ASX: COH) and Amcor Ltd (ASX: AMC) safe?
Geopolitical concerns sent the S&P/ASX 200 (ASX:XJO) down 1% on Tuesday as Cochlear (ASX:COH) and Coles (ASX:COL) shares made headlines.
